---
title: Can Umbilical Cord Blood and Tissue Stem Cells Treat Cerebral Palsy?
date: 2022-03-24T03:00:00-04:00
author: Casey Stoneman Roberson
canonical_url: "https://www.americordblood.com/articles/can-umbilical-cord-blood-and-tissue-stem-cells-treat-cerebral-palsy"
section: Articles
---
![A mother and father kissing their daughter on Christmas.](https://assets.americordblood.com/transforms/blogs/74200/americord-young-family-kissing-daughter-christmas_dcd4b851eab0fdc82c7554dc6e8ca81c.png)    [  Treatments &amp; Clinical Trials  ](https://www.americordblood.com/articles/treatments-clinical-trials) 

 4 Min Read 

 

# Can Umbilical Cord Blood and Tissue Stem Cells Treat Cerebral Palsy?

[1 in every 345 children](https://archive.cdc.gov/www_cdc_gov/ncbddd/cp/research.html) are living with Cerebral Palsy, making it one of the most common motor function disabilities in children.

Cerebral palsy (CP) is a devastating disorder. It permanently damages muscle coordination and body movement. CP is caused by atypical brain development or damage to the developing brain that impacts the child’s ability to control their movements.

## When are Children Diagnosed with Cerebral Palsy?

The majority of cerebral palsy cases (85%-90%) occur prior to or during birth and fall into the category of congenital CP. Some of the causes can include premature birth, low birthweight, medical issues during pregnancy or at the time of birth, or illnesses and injuries as a newborn or infant. Early signs of CP can be observed as early as 6 months with most developmental delays identified by 30 months.

    ![Image depicting four types of cerebral palsy - spastic, dyskinetic, ataxic, and mixed.](https://assets.americordblood.com/transforms/blogs/32843/4-types-of-cerebral-palsy-americord_798208f80960a64be1fb71800f1001dd.png) ### Is there a Cure for Cerebral Palsy?

Cerebral Palsy is a permanent neurological condition with no known cure. However, there are new promising areas of research using stem cells derived from umbilical cord blood and umbilical cord tissue as treatment options. These treatments may help improve your child’s motor function.

## Recent Clinical Trials for Cerebral Palsy

**Study #1: Autologous Cord Blood Stem Cell Infusion**

A [phase II trial](https://pubmed.ncbi.nlm.nih.gov/29080265/) of autologous cord blood stem cell infusion in children with cerebral palsy was conducted to determine whether autologous stem cell infusion could improve gross motor function.

In a double-blind, randomized control trial, 63 children, ages 1 to 6 years, were placed in the cord blood stem cell treatment group or the placebo control group. The treatment group received a single intravenous infusion of 10 to 50 million cells per kilogram (kg) of body weight.

While there were no significant differences between the stem cell treatment group versus the placebo control group at 1 year, further analyses demonstrated that there was a significant improvement in motor function and developmental motor scales at a dose of 20 million cells per kg versus those patients receiving a dose less than 20 million cells per kg.

***Key Takeaway:** This study demonstrated that a minimum dose of 20 million cells per kg of autologous cord blood stem cells was necessary to demonstrate a significant improvement in motor function 1 year post-treatment.*

**Study #2: Autologous / Allogeneic Cord Blood Stem Cell Infusion**

In an [open-label study](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380440/), 15 children, aged 1 to 6 years, with moderate to severe spastic cerebral palsy were treated with a single infusion of [HLA matched](https://www.americordblood.com/should-i-bank-each-childs-stem-cells/) or partially matched sibling cord blood stem cells (&gt;25 million cells per kg). Over the 2 year observation period, there were 49 adverse events, but no adverse events related to the cord blood infusion including the absence of antibody formation against platelets, red blood cells, or donor-specific HLA antigens. Six months after the stem cell infusion, the children demonstrated improvements in gross motor function and developmental motor scales.

***Key Takeaway:** This study demonstrated that a minimum dose of 25 million cells per kg of autologous or sibling cord blood stem cells was able to achieve a significant improvement in motor function at 6 months with no adverse effects related to the infusion of cord blood.*

**Study #3: Umbilical Cord Blood Mesenchymal Stem Cell Infusion**

In single-blind, randomized [controlled trial](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898688/), 54 children, ages 3 – 12, were placed in the cord blood mesenchymal stem cell (CB-MSC) treatment group or the placebo control group. The treatment group received 4 infusions of CB-MSCs at a fixed dose of 50 million cells. The treatment group demonstrated significant improvements in gross motor function and comprehensive function assessment scores at 3, 6, 12, and 24 months post-treatment compared to the control group.

***Key Takeaway:** This study demonstrated that four infusions at a fixed dose of 50 million MSCs derived from cord blood were able to achieve significant improvements in motor function starting at 3 months and continuing throughout the 24 month duration of the study.*

**Study #4: Umbilical Cord Tissue Mesenchymal Stem Cell Infusion**

In a double-blind, randomized [controlled trial](https://stemcellres.biomedcentral.com/articles/10.1186/s13287-019-1545-x), 40 children, ages 2-12, were placed in the cord tissue mesenchymal stem cell (CT-MSC) treatment group or the placebo control group. The treatment group received 4 doses of 45 to 55 million MSCs derived from the Wharton’s jelly of the cord tissue. There were no significant differences in the incidence rate of adverse events between the two groups. However, there were significant improvements in activities of daily living, comprehensive function assessment, and gross motor function scores.

***Key Takeaway:** The study demonstrated that four doses of 45 to 55 million MSCs derived from Wharton’s jelly were able to demonstrate significant improvement in motor function and activities of daily living without any significant differences in the incidence of adverse events.*

    ![Call to action guiding readers to download the Americord info guide to prepare for their family's future.](https://assets.americordblood.com/transforms/blogs/110628/prepare-for-future-info-guide-americord_be7aaffd48750bec4e355d7110544d3f.png) *The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.*

 

  ### Cord Tissue Banking

Preserve your baby’s umbilical cord tissue with CryoMaxx™ Processing and unlock the full potential for the entire family. Use in 100’s of clinical trials including Cerebral Palsy, Parkinson’s, surgical applications, and more.

 [ View Service ](https://www.americordblood.com/cord-tissue) 

### Be the First to Know

Never miss the latest cord blood breakthrough, clinical trial, or stem cell education to keep your family healthy for life.

  Sign Up  

    

  

 

 

 

 

 Share [  ](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcan-umbilical-cord-blood-and-tissue-stem-cells-treat-cerebral-palsy "Facebook") [  ](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcan-umbilical-cord-blood-and-tissue-stem-cells-treat-cerebral-palsy "LinkedIn") [  ](mailto:?body=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcan-umbilical-cord-blood-and-tissue-stem-cells-treat-cerebral-palsy "Email") 

 

  

## Related Articles

 [    ![A graphic depicting clinical trial for cerebral palsy treatment using cord blood stem cells.](https://assets.americordblood.com/transforms/blogs/8016/cerebral-palsy-treatment-cord-blood-americord_41a4f2ed037c5ad51696884668d44cc6.png)  ](https://www.americordblood.com/articles/duke-university-clinical-trial-promise-treating-cerebral-palsy) [### 2014 Duke University Clinical Trial Shows Promise Treating Cerebral Palsy

 ](https://www.americordblood.com/articles/duke-university-clinical-trial-promise-treating-cerebral-palsy)Let's look into how a clinical trial at Duke University is testing the viability of treating Cerebral Palsy with cord blood stem cells.

 

 [ Read More ](https://www.americordblood.com/articles/duke-university-clinical-trial-promise-treating-cerebral-palsy) 

 

 [    ![A graphic of a brain inside human head silhouette.](https://assets.americordblood.com/transforms/blogs/62102/motor-function-cerebral-palsy-americord_41a4f2ed037c5ad51696884668d44cc6.png)  ](https://www.americordblood.com/articles/can-cord-blood-stem-cell-therapy-improve-cerebral-palsy-motor-function) [### Can Cord Blood Stem Cell Therapy Improve Cerebral Palsy Motor Function?

 ](https://www.americordblood.com/articles/can-cord-blood-stem-cell-therapy-improve-cerebral-palsy-motor-function)Cerebral Palsy is a disorder that affects many people worldwide. As research advances, many question the role of cord blood stem cell treatments.

 

 [ Read More ](https://www.americordblood.com/articles/can-cord-blood-stem-cell-therapy-improve-cerebral-palsy-motor-function) 

 

 [    ![Picture depicting the words FDA APPROVE on a white background.](https://assets.americordblood.com/transforms/blogs/6169/top-10-fda-approved-illnesses-americord_41a4f2ed037c5ad51696884668d44cc6.png)  ](https://www.americordblood.com/articles/top-10-fda-approved-treatments-using-cord-blood-stem-cells) [### Top 10 FDA-Approved Treatments Using Cord Blood Stem Cells

 ](https://www.americordblood.com/articles/top-10-fda-approved-treatments-using-cord-blood-stem-cells)Cord blood stem cells are FDA-approved to treat over 80 conditions and diseases. Americord breaks down the Top 10 Treatments using cord blood stem cells today.

 

 [ Read More ](https://www.americordblood.com/articles/top-10-fda-approved-treatments-using-cord-blood-stem-cells)
